Apart from these studies, the role of miR-143 in modulating HK2 has been reported in various cancers like colon cancer, esophageal squamous cell carcinoma, lung cancer, cervical carcinoma, liposarcoma, bladder cancer, osteosarcoma, and gastric cancer [62,63,65,66]. This evidence concerns the gene HK2 and lung carcinoma.